IAGX Stock Overview
Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Imagenetix, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.003 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -92.59% |
| 5 Year Change | -96.00% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| IAGX | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | 0.3% |
| 1Y | n/a | -26.7% | 26.2% |
Return vs Industry: Insufficient data to determine how IAGX performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how IAGX performed against the US Market.
Price Volatility
| IAGX volatility | |
|---|---|
| IAGX Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 10.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IAGX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IAGX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Decky Goodrich | https://www.imagenetix.net |
Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health. The company also licenses its intellectual property to third parties.
Imagenetix, Inc. Fundamentals Summary
| IAGX fundamental statistics | |
|---|---|
| Market cap | US$5.71k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs IAGX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IAGX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
Mar 31, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did IAGX perform over the long term?
See historical performance and comparison